Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Tharimmune, Inc.

Equities

THAR

US4327053090

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
3.35 USD +0.30% Intraday chart for Tharimmune, Inc. -35.58% -56.12%
Jun. 10 Tharimmune, Inc. Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-To-Severe Pruritus in Primary Biliary Cholangitis CI
May. 25 Certain Warrants of Tharimmune, Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2024. CI
6159e3cf705358d83ce84.lDSKq-tzUu8E_TC46mvAquL3jyB0_fgnAYPY0huW4Ck.x0fL8qxHGLBCxXzChAGu7LORv0crpKxdLNaro1j-kW7zdcnqsgU6mTW1Ww~866dc911e87eea5d769fc24a40f1564a
  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Charts Tharimmune, Inc.
  5. News Chart